When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRTX - Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors
Cortexyme Inc.
Cortexyme (NASDAQ: CRTX) stock has been hammered in response to a failed clinical trial for its experimental Alzheimer's disease treatment. The clinical-stage biotech stock immediately plummeted 75%, catching many investors by surprise.
If you're new to biotech investing , there are some important lessons to be learned from the failure Cortexyme recently reported. Here's what you need to know in order to avoid heavy losses in the future.